Short interfering RNA-mediated gene silencing; towards successful application in human patients

Advanced Drug Delivery Reviews

Volumn 61, Issue 9, 2009, Pages 668-671

  Siomi, Mikiko C ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Argonaute; DICER; miRNA; RNAi; siRNA

Indexed keywords

DISEASE CONTROL; GENE EXPRESSION; GENETIC ENGINEERING; MACHINERY; RNA;

ARGONAUTE; DICER; MIRNA; RNAI; SIRNA;

NUCLEIC ACIDS;

DOUBLE STRANDED RNA; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE;

EID: 65749119430     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.04.008     Document Type: Note

References (56)

1. Fire A., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in C. elegans. Nature 391 (1998) 806-811
2. Jorgensen R.A. Sense cosuppression in plants: past, present and future. RNAi: a guide to gene silencing (2003) 5-21 Chapter 1
3. Matzke M.M., Mette M.F., Kanno T., Aufsatz W., and Matzke A.J.M. Regulation of the genome by double-stranded RNA. RNAi: a guide to gene silencing (2003) 43-63 Chapter 3
4. Kennerdell J.R., and Carthew R.W. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled2 act in the wingless pathway. Cell 95 (1998) 1017-1026
5. Clemens J.C., Worby C.A., Siomonson-Leff N., Muda M., Maehama T., Hemmings B.A., and Dixon J.E. Use of double-stranded RNA interference in Drosophila cell line to dissect signal transduction pathways. Proc. Natl. Acad. Sci. USA 97 (2000) 6499-6503
6. Hammond S.M., Bernstein E., Beach D., and Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404 (2000) 293-296
7. Ding S.W., and Voinnet O. Antiviral immunity directed by small RNAs. Cell 130 (2007) 413-426
8. Girard A., and Hannon G.J. Conserved themes in small RNA-mediated transposon control. Trends Cell Biol. 18 (2008) 136-148
9. Stefani G., and Slack F.J. Small non-coding RNAs in animal development. Nat. Rev., Mol. Cell Biol. 9 (2008) 219-230
10. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
11. Elbashir S.M., Haborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
12. Provost P., Dishart D., Doucet J., Frendewey D., Samuelsson B., and Radmark O. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J. 21 (2002) 5864-5874
13. Zhang H., Kolb F.A., Jaskiewicz L., Westhof E., and Filipowicz W. Silencing processing center models for human Dicer and bacterial RNase III. Cell 118 (2004) 57-68
14. Bernstein E., Caudy A.A., Hammond S.M., and Hannon G.J. Role for a bidentate ribonucluease in the initiation step of RNA interference. Nature 409 (2001) 363-366
15. Lee Y.S., Nakahara K., Pham J.W., Kim K., He Z., Sontheimer E.J., and Carthew R.W. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117 (2004) 69-81
16. Jinek M., and Doudna J.A. A three-dimensional view of the molecular machinery of RNA interference. Nature 457 (2009) 405-412
17. Siomi H., and Siomi M.C. On the road to reading the RNA-interference code. Nature 457 (2009) 396-404
18. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nichikura K., and Shiekhatter R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436 (2005) 740-744
19. Haase A.D., Jaskiewicz L., Zhang H., Laine S., Sack R., Gatignol A., and Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression. EMBO Rep. 6 (2005) 961-967
20. Liu Q., Rand T.A., Kalidas S., Du F., Kim H.E., Smith D.P., and Wang X. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 301 (2003) 1921-1925
21. Lee Y., Hur I., Park S.Y., Kim Y.K., Suh M.R., and Kim V.N. The role of PACT in the RNA silencing pathway. EMBO J. 25 (2006) 522-532
22. Gregory R.I., Chendrimada T.P., Cooch N., and Shiekhatter R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123 (2005) 631-640
23. Maniataki E., and Mourelatos Z.A. Human, ATP-dependent, RISC assembly machine fueled by pre-miRNA. Genes Dev. 19 (2005) 2979-2990
24. MacRae I.J., Ma E., Zhou M., Robinson C.V., and Doudna J.A. In vitro reconstitution of the human RISC-loading complex. Proc. Natl. Acad. Sci. USA 105 (2008) 512-517
25. Hannon G.J. RNA interference. Nature 418 (2003) 244-251
26. Martinez J., and Tuschl T. RISC is a 5′ phosphomonoester-producing RNA endonuclease. Genes Dev. 18 (2004) 975-980
27. Tomari Y., Matranga C., Haley B., Martinez N., and Zamore P.D. A protein sensor for siRNA asymmetry. Science 306 (2004) 1377-1380
28. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., Hammond S.M., Joshua-Tor L., and Hannon G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (2004) 1437-1441
29. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., and Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15 (2004) 185-197
30. Song J.J., Smith S.K., Hannon G.J., and Joshua-Tor L. Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305 (2004) 1434-1437
31. Hutvagner G., and Simard M.J. Argonaute proteins: key players in RNA silencing. Nat. Rev., Mol. Cell Biol. 9 (2008) 22-32
32. Song J.J., Liu J., Tolia N.H., Schneiderman J., Smith S.K., Martienssen R.A., Hannon G.J., and Joshua-Tor L. The crystal structure of the Argonaute2 PAZ domain reveals as RNA binding motif in RNAi effector complexes. Nat. Struct. Mol. Biol. 10 (2003) 1026-1032
33. Ma J.B., Yuan Y.R., Meister G., Pei Y., Tushl T., and Patel D.J. Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Nature 434 (2005) 666-670
34. Nowotny M., Gaidanakov S.A., Crouch R.J., and Yang W. Crystal structure of RNaseH bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis. Cell 121 (2005) 1005-1016
35. Khvorova A., Reynolds A., and Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115 (2003) 209-216
36. Schwarz D.S. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115 (2003) 119-208
37. Matranga C., Tomari Y., Shin C., Bartel D.P., and Zamore P.D. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123 (2005) 607-620
38. Miyoshi K., Tsukumo H., Nagami T., Siomi H., and Siomi M.C. Slicer function of Drosophila Argonautes and its involvement in RISC formation. Genes Dev. 19 (2005) 2837-2848
39. Rand T.A., Petersen S., Du F., and Wang X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123 (2005) 621-629
40. Gantier M.P., and Williams B.R. The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev. 18 (2007) 363-371
41. Kim D.H., Behlke M.A., Rose S.D., Chang M.S., Choi S., and Rossi J.J. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23 (2005) 222-226
42. Azuma-Mukai A., Oguri H., Mituyama T., Qian Z.R., Asai K., Siomi H., and Siomi M.C. Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc. Natl. Acad. Sci. USA 105 (2008) 7964-7969
43. Kim V.N., Han J., and Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev., Mol. Cell Biol. 10 (2009) 126-139
44. Brodersen P., and Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat. Rev., Mol. Cell Biol. 10 (2009) 141-147
45. Eulalio A., Behm-Ansmant I., and Izzauralde E. P bodies: at the crossroads of post-transcriptional pathways. Nat. Rev., Mol. Cell Biol. 8 (2007) 9-22
46. Doench J.G., Petersen C.P., and Sharp P.A. siRNAs can function as miRNAs. Genes Dev. 17 (2003) 438-442
47. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazaf F., and Key M.A. Fatality in mice due to over saturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
48. Tam O.H., Aravin A.A., Stein P., Girard A., Murchison E.P., Chwloufi S., Hodges E., Anger M., Sachidanandam R., Schultz R.M., and Hannon G.J. Pseudogene-derived small interfering RNAs regulates gene expression in mouse oocytes. Nature 453 (2008) 534-538
49. Watanabe T., et al. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts on mouse oocytes. Nature 453 (2008) 539-543
50. Diederichs S., and Haber D.A. Dual role for argonatues in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131 (2007) 1097-1108
51. Diederichs S., Jung S., Rothenberg S.M., Smolen G.A., Mlody B.G., and Haber D.A. Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. Proc. Natl. Acad. Sci. USA 105 (2008) 9284-9289
52. Castanotto D., and Rossi J. The premises and pitfalls of RNA-interference-base therapeutics. Nature 457 (2009) 426-433
53. Morrissey D.V., Lockridge J.A., Shaw L., Blanchard K., Jensen K., Breen W., Hartsough K., Machemer L., Radka S., Jadhav V., Vaish N., Zinnen S., Vargeese C., Bowman K., Shaffer C.S., Jeffs J.B., Judge A., MacLachlan I., and Polisky B. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23 (2005) 1002-1007
54. Lorenz C., Hadwiger P., John M., Vornlocher H.P., and Unverzagt C. Steroid and lipid conjugates of siRNAs ti enhance cellular uptake and gene silencing in liver cells. Bioorg. Med. Chem. Lett. 14 (2004) 4975-4977
55. Bartless D.W., Su H., Hidebrandt I.J., Weber W.A., and Davis M.E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticle measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. USA 104 (2007) 15549-15554
56. Soutschek J., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178